Review paper
Effect of anti-VEGF treatment on nonperfusion areas in ischemic retinopathy
Volume: 14, Issue: 11, Pages: 1647 - 1652
Published: Nov 18, 2021
Abstract
In recent years, retinal ischemia such as that which occurs in diabetic retinopathy (DR) and retinal vein occlusion (RVO) has become a hotspot of ischemic retinopathy research. High levels of vascular endothelial growth factor (VEGF) are recognized as a major cause of macular edema (ME) in DR and RVO. High concentrations of VEGF in the vitreous can lead to serious retinal ischemia and hypoxia and form retinal nonperfusion areas (NPAs). Different...
Paper Details
Title
Effect of anti-VEGF treatment on nonperfusion areas in ischemic retinopathy
Published Date
Nov 18, 2021
Volume
14
Issue
11
Pages
1647 - 1652
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History